News from Icon, AbelsonTaylor and Chiltern – People on the move

By Natalie Morrison

- Last updated on GMT

Related tags: Medicine

Outsourcing-Pharma presents its weekly round-up of the latest career changes within the pharmaceutical industry, including news from Icon, AbelsonTaylor and Chiltern.

David Raunig​ has become the new VP of informatics at Icon Medical ​Imaging.

Formerly a project lead statistician for Alzheimer’s disease studies at Pfizer, Raunig joins the firm with 25 years experience in research and 15 years experience in pharmaceutical research statistics and study design.

The company has also drafted in Scott Neff​ as VP of business development for Icon Development Solutions.

Prior to his new appointment, Neff managed the sales process for multiple strategic accounts at Qunitiles, specifically focusing on Phase I Clinical trials and Cardiac Safety.

Computer-based solutions provier for health and human services organisations Netsmart​ has appointed Dennis Morrison​ as CCO.

A key opinion leader in clinical behavioural health, Morrison will lead the development team focusing on evidence-based practice, recovery- and research-based care, coordinated care planning, and the integration of behavioral and primary care.

Before Netsmart he was CEO at Centerstone’s research institute – a private, not-for-profit mental health research and information technology company.

"I've always believed information technology can play a key role in revolutionizing the way healthcare is delivered,"​ said Morrison. "Netsmart's experience, commitment to innovation, large client base, domain expertise, and industry leadership make it the one technology provider with the vision and resources to make this clinical impact a reality on a broad scale."

Chiltern​ has named Marcelo Piccirillo​ and Carlo Lanza​ as senior clinical research physicians.

Piccirillo, who will work for the firm’s Wilmington, US, office, will focus specifically on gastroenterology therapy. He has spent the past five years working on therapies inflammatory bowel disease and colonic transit disorders.

Lanza will work from the office in Milan, Italy, and is a member of the Italian Medical Order, as well as the American Society of Haematology.

In his new role he will support the company’s growth in oncology and haematology.

PerkinElmer ​has placed Peter Barrett ​on the board of directors. The firm says Barrett’s appointment is in preparation of a current board member’s retirement.

Barret is currently a partner at Atlas Venture, an early stage life sciences and tech venture capital company.

Robert Friel, chairman and CEO at PerkinElmer, said: “Peter brings decades of deep industry experience and knowledge of life sciences and analytical instrumentation, gained in his international leadership positions, as well as from his expertise as a leading investor in scientific enterprises.”

Pharmaceutical eConsulting​ (PeC) has appointed Shylendra Kumar​ as senior principal consultant.

In his new role, Kumar will work on the establishment of innovative consulting services for the life science industry, developing strategies and plans to execute the US business.

Kumar was formerly president and CEO of Datafarm, which has recently become part of regulatory management services bod Liquent.

"The speed at which PeC has become one of the leading electronic submission services providers in Europe is staggering,"​ said Kumar. "I look forward at the opportunity to extend such unprecedented market leadership world-wide."

Related topics: Markets & Regulations

Related news

Show more

Follow us


View more